Cargando…

SARS-CoV-2 infection in patients with primary central nervous system lymphoma

BACKGROUND: Cancer patients may be at higher risk for severe coronavirus infectious disease-19 (COVID-19); however, the outcome of Primary Central Nervous System Lymphoma (PCNSL) patients with SARS-CoV-2 infection has not been described yet. METHODS: We conducted a retrospective study within the Lym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurenge, Alice, Ursu, Renata, Houillier, Caroline, Abdi, Basma, Tebano, Gianpiero, Quemeneur, Cyril, Choquet, Sylvain, Di Blasi, Roberta, Lozano, Fernando, Morales, Andrea, Durán-Peña, Alberto, Sirven-Villaros, Lila, Mathon, Bertrand, Mokhtari, Karima, Bielle, Franck, Martin-Duverneuil, Nadine, Delattre, Jean-Yves, Marcelin, Anne-Geneviève, Pourcher, Valérie, Alentorn, Agusti, Idbaih, Ahmed, Carpentier, Antoine F., Leblond, Véronique, Hoang-Xuan, Khê, Touat, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776286/ https://www.ncbi.nlm.nih.gov/pubmed/33387015 http://dx.doi.org/10.1007/s00415-020-10311-w

Ejemplares similares

Infection par le SARS-CoV 2 chez les patients avec lymphome cérébral primitif du système nerveux central : étude préliminaire de la sévérité et des facteurs pronostics
por: Laurenge, Alice, et al.
Publicado: (2021)

Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
por: Hernández-Verdin, Isaias, et al.
Publicado: (2022)

Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity
por: Chabaane, Mohamed, et al.
Publicado: (2020)

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
por: Lesueur, Paul, et al.
Publicado: (2022)

Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin’s Lymphomas from Genome-Wide Association Studies
por: Hernández-Verdin, Isaias, et al.
Publicado: (2020)

Manifestations cliniques et facteurs pronostiques de la COVID-19 chez les patients souffrant de gliome diffus
por: Lozano, Fernando, et al.
Publicado: (2021)

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients
por: Cuzzubbo, Stefania, et al.
Publicado: (2020)

Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic
por: Lozano-Sanchez, Fernando, et al.
Publicado: (2021)

Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases
por: Tétu, Pauline, et al.
Publicado: (2020)

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
por: Kamoun, Aurélie, et al.
Publicado: (2016)

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
por: Idbaih, Ahmed, et al.
Publicado: (2010)

Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
por: Salam, Rana, et al.
Publicado: (2023)

Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
por: Appay, Romain, et al.
Publicado: (2018)

Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
por: Rozenblum, Laura, et al.
Publicado: (2022)

Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
por: Ducray, François, et al.
Publicado: (2008)

NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas
por: Benetkiewicz, Magdalena, et al.
Publicado: (2009)

Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes
por: Vessières, Anne, et al.
Publicado: (2021)

Brain Metabolic Alterations in Seropositive Autoimmune Encephalitis: An (18)F-FDG PET Study
por: Bergeret, Sébastien, et al.
Publicado: (2023)

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
por: Grandin, Nathalie, et al.
Publicado: (2019)

Neurological Syndromes Associated with Anti-GAD Antibodies
por: Dade, Maëlle, et al.
Publicado: (2020)

Vaccination contre le SARS-CoV-2 avant l’introduction d’un traitement par anti-CD20 chez les patients atteints de sclérose en plaques : une protection durable ?
por: Jeantin, Lina, et al.
Publicado: (2023)

Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
por: Belin, Catherine, et al.
Publicado: (2020)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

S232: EFFICACY AND TOXICITY OF CAR-T CELLS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS, A NEW REFERENCE: THE FRENCH EXPERIENCE OF THE NATIONAL LOC NETWORK
por: Choquet, Sylvain, et al.
Publicado: (2023)

Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations
por: Bouzidi, Amira, et al.
Publicado: (2021)

Rare Neuronal, Glial and Glioneuronal Tumours in Adults
por: Crainic, Nicolas, et al.
Publicado: (2023)

Intraoperative Ultrasound Shear-Wave Elastography in Focal Cortical Dysplasia Surgery
por: Mathon, Bertrand, et al.
Publicado: (2021)

Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies
por: Dade, Maëlle, et al.
Publicado: (2021)

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
por: Euskirchen, Philipp, et al.
Publicado: (2017)

Temporary disruption of the blood-brain barrier using an implantable ultrasound system for recurrent glioblastoma patients under IV carboplatin chemotherapy: initial phase 1/2a clinical trial observations
por: Carpentier, Alexandre, et al.
Publicado: (2015)

Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
por: Morales-Martinez, Andrea, et al.
Publicado: (2021)

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics
por: Mazzocco, P, et al.
Publicado: (2015)

Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics
por: Lasri, Ayoub, et al.
Publicado: (2020)

Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma
por: Verreault, Maïté, et al.
Publicado: (2022)

Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective
por: Thomas, Alice, et al.
Publicado: (2023)

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
por: Vialatte de Pémille, Clément, et al.
Publicado: (2018)

Quantifying the heritability of glioma using genome-wide complex trait analysis
por: Kinnersley, Ben, et al.
Publicado: (2015)

Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation
por: Berzero, Giulia, et al.
Publicado: (2019)

Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2023)

Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
por: Labreche, Karim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c98ebsg7llituevn8gdkla9pq8